NCT02462629View on ClinicalTrials.gov

Study of BLZ-100 in Pediatric Subjects With CNS Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

July 31, 2018

Study Completion Date

August 31, 2018

Conditions
Central Nervous System Tumors
Interventions
DRUG

BLZ-100

Trial Locations (1)

98105

Seattle Children's, Seattle

Sponsors
All Listed Sponsors
lead

Blaze Bioscience Inc.

INDUSTRY